Antitumor efficacy of a urokinase activation-dependent anthrax toxin

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Antitumor efficacy of a urokinase activation-dependent anthrax toxin. / Rono, B.; Romer, J.; Liu, S.; Bugge, T.H.; Leppla, S.H.; Kristjansen, Paul Ejnar Gremaud.

I: Molecular Cancer Therapeutics, Bind 5, Nr. 1, 2006, s. 89-96.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Rono, B, Romer, J, Liu, S, Bugge, TH, Leppla, SH & Kristjansen, PEG 2006, 'Antitumor efficacy of a urokinase activation-dependent anthrax toxin', Molecular Cancer Therapeutics, bind 5, nr. 1, s. 89-96.

APA

Rono, B., Romer, J., Liu, S., Bugge, T. H., Leppla, S. H., & Kristjansen, P. E. G. (2006). Antitumor efficacy of a urokinase activation-dependent anthrax toxin. Molecular Cancer Therapeutics, 5(1), 89-96.

Vancouver

Rono B, Romer J, Liu S, Bugge TH, Leppla SH, Kristjansen PEG. Antitumor efficacy of a urokinase activation-dependent anthrax toxin. Molecular Cancer Therapeutics. 2006;5(1):89-96.

Author

Rono, B. ; Romer, J. ; Liu, S. ; Bugge, T.H. ; Leppla, S.H. ; Kristjansen, Paul Ejnar Gremaud. / Antitumor efficacy of a urokinase activation-dependent anthrax toxin. I: Molecular Cancer Therapeutics. 2006 ; Bind 5, Nr. 1. s. 89-96.

Bibtex

@article{19d05a3070ec11dcbee902004c4f4f50,
title = "Antitumor efficacy of a urokinase activation-dependent anthrax toxin",
abstract = "Udgivelsesdato: 2006/1",
author = "B. Rono and J. Romer and S. Liu and T.H. Bugge and S.H. Leppla and Kristjansen, {Paul Ejnar Gremaud}",
year = "2006",
language = "English",
volume = "5",
pages = "89--96",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research (A A C R)",
number = "1",

}

RIS

TY - JOUR

T1 - Antitumor efficacy of a urokinase activation-dependent anthrax toxin

AU - Rono, B.

AU - Romer, J.

AU - Liu, S.

AU - Bugge, T.H.

AU - Leppla, S.H.

AU - Kristjansen, Paul Ejnar Gremaud

PY - 2006

Y1 - 2006

N2 - Udgivelsesdato: 2006/1

AB - Udgivelsesdato: 2006/1

M3 - Journal article

VL - 5

SP - 89

EP - 96

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 1

ER -

ID: 1206307